Patients coinfected with HIV and hepatitis C genotype 1 show high response rates to a three-drug regimen of ombitasvir, paritaprevir codosed with rito... More »
DNA damage to skin continues for hours after UVA exposure ceases, and melanin is a key culprit in the process, based on the results of cell cultures a... More »
Men with favorable intermediate-risk prostate cancer could be considered for active surveillance, say the authors of a study, published in JAMA Oncolo... More »
The immunogenicity and efficacy of the recently approved 9-valent human papillomavirus vaccine were similar to that of the currently approved and reco... More »
The immunogenicity and efficacy of the recently approved 9-valent human papillomavirus vaccine were similar to that of the currently approved and reco... More »
Adding radiotherapy to androgen-deprivation therapy for locally advanced prostate cancer improves overall survival 30% in the long term, according to ... More »
HPV-16-E6 seropositivity is relatively common among people who later develop anal cancer, and less common but still more frequent than normal among pe... More »
HPV-16-E6 seropositivity is relatively common among people who later develop anal cancer, and less common but still more frequent than normal among pe... More »
Current, short-term use of hormone replacement therapy led to a 43% increase in risk of serous and endometrioid ovarian cancers, according to a large ... More »
Current, short-term use of hormone replacement therapy led to a 43% increase in risk of serous and endometrioid ovarian cancers, according to a large ... More »